09:32 AM EDT, 06/09/2025 (MT Newswires) -- Citius Pharmaceuticals ( CTXR ) unit Citius Oncology ( CTOR ) said Monday it signed a distribution agreement with Cardinal Health ( CAH ) to support the commercial US rollout of Lymphir, a treatment for adults with relapsed or refractory cutaneous T-cell lymphoma.

Financial terms were not provided.

Cardinal Health ( CAH ) will serve as an authorized distributor for the FDA-approved drug, Citius Oncology ( CTOR ) said.

Price: 1.05, Change: +0.08, Percent Change: +8.25